Water Extract of Fructus Hordei Germinatus Shows Antihyperprolactinemia Activity via Dopamine D2 Receptor

被引:4
作者
Wang, Xiong [1 ]
Ma, Li [1 ]
Zhang, En-jing [1 ]
Zou, Ji-li [1 ]
Guo, Hao [2 ]
Peng, Si-wei [2 ]
Wu, Jin-hu [1 ]
机构
[1] Third Hosp Wuhan, Dept Pharm, Wuhan 430060, Hubei, Peoples R China
[2] Hubei Univ Tradit Chinese Med, Coll Pharm, Wuhan 430065, Hubei, Peoples R China
关键词
CLONAL CELL-LINE; HYPERPROLACTINEMIA; BROMOCRIPTINE; EXPRESSION; APOPTOSIS; DIAGNOSIS; AGONISTS;
D O I
10.1155/2014/579054
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objective. Fructus Hordei Germinatus is widely used in treating hyperprolactinemia (hyperPRL) as a kind of Chinese traditional herb in China. In this study, we investigated the anti-hyperPRL activity of water extract of Fructus Hordei Germinatus(WEFHG) and mechanism of action. Methods. Effect of WEFHG on serum prolactin (PRL), estradiol (E2), progesterone (P), follicle-stimulating hormone (FSH), luteinizing hormone (LH), and hypothalamus protein kinase A (PKA) and cyclic adenosine monophosphate (cAMP) levels of hyperPRL rats were investigated. And effect of WEFHG on PRL secretion, D2 receptors, and dopamine transporters (DAT) was studied in MMQ, GH3, and PC12 cells, respectively. Results. WEFHG reduced the secretion of PRL in hyperPRL rats effectively. In MMQ cell, treatment with WEFHG at 1-5 mg/mL significantly suppressed PRL secretion and synthesis. Consistent with a D2-action, WEFHG did not affect PRL in rat pituitary lactotropic tumor-derived GH3 cells that lack the D2 receptor expression but significantly increased the expression of D2 receptors and DAT in PC12 cells. In addition, WEFHG reduced the cAMP and PKA levels of hypothalamus in hyperPRL rats significantly. Conclusions. WEFHG showed anti-hyperPRL activity via dopamine D2 receptor, which was related to the second messenger cAMP and PKA.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] TIPEPIDINE ACTIVATES VTA DOPAMINE NEURON VIA INHIBITING DOPAMINE D2 RECEPTOR-MEDIATED INWARD RECTIFYING K+ CURRENT
    Hamasaki, R.
    Shirasaki, T.
    Soeda, F.
    Takahama, K.
    NEUROSCIENCE, 2013, 252 : 24 - 34
  • [32] Dopamine D2 Receptor-Mediated Regulation of Pancreatic β Cell Mass
    Sakano, Daisuke
    Choi, Sungik
    Kataoka, Masateru
    Shiraki, Nobuaki
    Uesugi, Motonari
    Kume, Kazuhiko
    Kume, Shoen
    STEM CELL REPORTS, 2016, 7 (01): : 95 - 109
  • [33] Regulatory roles of dopamine D2 receptor in milk protein production and apoptosis in mammary epithelial cells
    Han, Liang
    Lu, Shan-Ni
    Nishimura, Takanori
    Kobayashi, Ken
    EXPERIMENTAL CELL RESEARCH, 2024, 439 (01)
  • [34] Structural insights into the human D1 and D2 dopamine receptor signaling complexes
    Zhuang, Youwen
    Xu, Peiyu
    Mao, Chunyou
    Wang, Lei
    Krumm, Brian
    Zhou, X. Edward
    Huang, Sijie
    Liu, Heng
    Cheng, Xi
    Huang, Xi-Ping
    Shen, Dan-Dan
    Xu, Tinghai
    Liu, Yong-Feng
    Wang, Yue
    Guo, Jia
    Jiang, Yi
    Jiang, Hualiang
    Melcher, Karsten
    Roth, Bryan L.
    Zhang, Yan
    Zhang, Cheng
    Xu, H. Eric
    CELL, 2021, 184 (04) : 931 - +
  • [35] Talipexole variations as novel bitopic dopamine D2 and D3 receptor ligands
    Stank, Lars
    Frank, Annika
    Hagenow, Stefanie
    Stark, Holger
    MEDCHEMCOMM, 2019, 10 (11) : 1926 - 1929
  • [36] Comparison of brain activity between dopamine D2 receptor-knockout and wild mice in response to dopamine agonist and antagonist assessed by fMRI
    Kuriwaki, J
    Nishijo, H
    Kondoh, T
    Uwano, T
    Torii, K
    Katsuki, M
    Ono, T
    NEUROSIGNALS, 2004, 13 (05) : 227 - 240
  • [37] AGONIST AND ANTAGONIST ACTIVITY OF LOW EFFICACY D2 DOPAMINE RECEPTOR AGONISTS IN RATS DISCRIMINATING D-AMPHETAMINE FROM SALINE
    EXNER, M
    CLARK, D
    BEHAVIOURAL PHARMACOLOGY, 1992, 3 (06): : 609 - 619
  • [38] Structure-Activity Relationships of Privileged Structures Lead to the Discovery of Novel Biased Ligands at the Dopamine D2 Receptor
    Szabo, Monika
    Herenbrink, Carmen Klein
    Christopoulos, Arthur
    Lane, J. Robert
    Capuano, Ben
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (11) : 4924 - 4939
  • [39] Locomotor activity induced by MK-801 is enhanced in dopamine D3 receptor knockout mice but suppression by dopamine D3/D2 antagonists does not occur through the dopamine D3 receptor
    Yarkov, Alex V.
    Der, Terry C.
    Joyce, Jeffrey N.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 627 (1-3) : 167 - 172
  • [40] Effects of D2 dopamine receptor agonist and antagonist on brain activity in the rat assessed by functional magnetic resonance imaging
    Hagino, H
    Tabuchi, E
    Kurachi, M
    Saitoh, O
    Sun, YJ
    Kondoh, T
    Ono, T
    Torii, K
    BRAIN RESEARCH, 1998, 813 (02) : 367 - 373